POCI’s specialized medical-device and defense/aerospace optical know-how must keep winning design-in roles that become repeat production programs, rather than remaining uneven project work. If design-ins convert, a small revenue base can scale; if they do not, the business remains a volatile engineering shop.

The custom-optics model must recover pricing, mix, or manufacturing yield advantage; otherwise POCI’s technical specialization is not translating into economic power. Gross margin is the bridge between technical differentiation and shareholder value; without recovery, growth could destroy cash.

POCI’s fixed engineering and manufacturing base must be better utilized, or costs must be reset, because the current scale is not absorbing overhead. Operating leverage is what would turn a niche technical position into per-share value; persistent underutilization keeps the equity dependent on external capital.

POCI must reduce operating cash burn before liquidity needs shift value from existing shareholders to new capital providers. Even a valid product-market thesis can be a poor stock if the company must issue equity or expensive debt before the turnaround appears.